Yury O. Chernoff

Yury O. Chernoff is a Professor in the School of Biological Sciences within the College of Sciences at Georgia Institute of Technology, where he also directs the Center for Nanobiology of the Macromolecular Assembly Disorders (NanoMAD). He serves as Editor-in-Chief of the scientific journal Prion and maintains an active research laboratory focused on protein aggregation disorders.

His educational background includes a Ph.D. in Biology from St. Petersburg State University (Russia, 1985), followed by postdoctoral research at Okayama University (Japan) and the University of Illinois at Chicago. This foundation established his expertise in molecular biology and protein science.

Chernoff's research centers on yeast models for protein aggregation disorders, with particular emphasis on cellular control of prion propagation, sequence-specificity of amyloid formation, and evolutionary conservation of prion properties. His laboratory pioneered the discovery of chaperone roles in prion phenomena and developed yeast systems for studying mammalian amyloids involved in neurodegenerative diseases. Current investigations explore stress-induced biomolecular condensates, planetary protection protocols for prion inactivation in space missions, and cross-species transmission barriers.

Analysis of his recent publications reveals expanding research frontiers into astrobiology applications, particularly regarding thermal and space condition effects on prion stability for Mars sample return missions. His work maintains strong focus on fundamental mechanisms of protein-based inheritance while developing novel yeast-based platforms for human amyloidogenic protein discovery.

Chernoff actively contributes to scientific infrastructure through his editorial leadership of Prion journal and direction of the NanoMAD center. His laboratory employs interdisciplinary approaches combining yeast genetics, biophysical analysis, and molecular modeling to investigate protein aggregation phenomena across biological contexts.

The laboratory maintains significant industry and institutional collaborations, particularly in developing decontamination protocols for space missions and diagnostic tools for amyloid-related disorders. Current projects include characterization of human chromatin modifier PHC3 prion-like properties and investigation of Aβ42-IAPP interactions relevant to Alzheimer's-diabetes comorbidity.